Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact email@example.com.
IDG and PICC jointly lead the investment, and Bain Capital remains the main shareholder
Shanghai – November 16, 2022 – China's leading private medical group, Asia Pacific Medical Group , today announced the successful completion of a round of financing of hundreds of millions of RMB, led by IDG Capital and PICC ( PICC) equity investment co-leads the investment, and GL Capital participates in the investment. This round of financing is the first round of external financing of Asia Pacific Medical Group, and the funds will be mainly used for the final construction of its Shanghai Xiehua Hospital and the acquisition of some hospitals. Since Bain Capital Private Equity acquired the controlling stake in Asia Pacific Medical in March 2016, through continuous construction and cultivation, it has formed a medical group featuring neurology and oncology.
Asia Pacific Medical Group CEO Pan Jie said: "As the pioneer of social medical management in China, Asia-Pacific Medical has adopted a combination of organic growth and M&A expansion. At present, it has formed the medical characteristics of neurology and oncology. It is a model of domestic social medical management and a differentiated supplement to public hospital resources. Today, we are honored to have introduced new capital and partners. In the future, we will work together with all investment institutions to provide patients with high-quality patient-centered medical services and build a high-quality social medical group in China. ”
Asia Pacific Medical Group was established in 1992 by a group of early Chinese doctors in the United States. It is an early foreign-funded medical institution that entered the field of medical services in China. After more than 20 years of development, it has gradually achieved remarkable development in the fields of neurosurgery, tumor treatment and high-end general practice services. At the same time, it has formed long-term strategic partnerships with many outstanding large public hospitals in China. At present, Asia Pacific Hospital operates 9 hospitals in China, including Beijing Tiantan Puhua Hospital, Beijing Nanjiao Cancer Hospital, Beijing Xinqidian Hospital of Integrated Traditional Chinese and Western Medicine, Zhengzhou Tiantan Puhua Hospital, Shanghai Gamma Hospital, Shanghai Xiehua Brain Hospital, Shanghai New Qidian Rehabilitation Hospital, Zhejiang Cilin Hospital, Jiangsu Zhenjiang Ruikang Hospital, etc.
Zhang Sai, partner of IDG Capital, said: "As a leading social medical institution in China, Asia Pacific Medical Group has abundant medical resources and comprehensive service capabilities. Development path. IDG Capital is honored to join hands with the company's highly combative management team, and will continue to assist and support Asia Pacific Medical Group's further development and growth in the future, building it into a platform enterprise in the domestic private medical service industry. "
Lu Hedong, Managing Director of PICC Equity Investment, said: " Asia Pacific Medical has always adhered to the corporate vision of " building a healthier world " and adhered to the value medical concept of customer first. A large hospital group with full life cycle service capabilities. PICC is very pleased to be a participant in this round of Asia Pacific Medical and hopes to work with other shareholders to help the future development of Asia Pacific Medical. At the same time, it will actively explore more fields and more In-depth innovation and cooperation will build a new model for the integrated development of medical insurance and create a better service experience for customers. ”
Li Zhenfu, founder of Defu Capital, said: "Defu Capital is one of the earliest institutions in China that began to focus on investing in China's medical and health industry . Deeply cultivate the medical industry, focus on investing in high-quality medical and health companies with long-term sustainable competitive advantages, and strive to become the most reliable partner of outstanding companies. With the support of the company and various capitals, Asia-Pacific Medical has achieved rapid development, and has now grown into a Chinese society A leading company in the medical field. Under the challenge of the epidemic, Asia Pacific Medical insists on bringing high-quality and safe medical services to patients! We are very honored to join hands with various capitals to promote the sustainable development of Asia Pacific Medical and meet the challenges. Seize opportunities and realize value. ”
About Asia Pacific Medical Group
Asia Pacific Medical Group ( hereinafter referred to as APMG) was established in 1992 by a group of early Chinese doctors in the United States. It is an early foreign-funded medical institution that entered China's medical service field. After more than 20 years of development, APMG has achieved remarkable development in the fields of neurosurgery, tumor treatment and high-end general practice services. At the same time, it has formed long-term strategic partnerships with many outstanding large public hospitals in China. In March 2016, APMG was acquired by Bain Capital, a well-known American private equity investment institution. In May 2017, APMG further acquired China Medical Group (China Medical Group Co., Ltd.), which was founded in China by the Dr. Frist family, the founder of HCA, an American hospital group. Healthcare Corporation (CHC for short) is the main asset, and the Dr. Frist family has accordingly become a minority shareholder of the APMG Group. APMG currently operates 9 hospitals in China. With the expansion of the group, APMG will further comprehensively improve the coverage of medical services in China. APMG follows the international medical quality management system, combines international level hospital management experience and medical resources, advocates the service concept of " taking patients as the core " , provides more suitable treatment and high-quality services for each patient, and contributes to the improvement of Chinese medical treatment. Quality and service efficiency contribute a modest amount.
About Bain Capital
Bain Capital is a leading global alternative investment firm with approximately $160 billion in assets under management, creating enduring value for our investors, teams, businesses and communities. Founded in 1984, Bain Capital pioneered a consulting-based private equity investment strategy, working with the management teams of investee companies to challenge traditional thinking with new insights, build great companies and improve company operations. We have gradually expanded this approach organically across other asset classes to build one of the world's most robust alternative asset platforms.